{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T19:02:15Z","timestamp":1785438135517,"version":"3.56.0"},"reference-count":44,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Lausanne Orthopedic Research Foundation"},{"id":[{"id":"https:\/\/ror.org\/05wxfpw56","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Competence Center for Applied Biotechnology and Molecular Medicine","award":["02\/2018"],"award-info":[{"award-number":["02\/2018"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bioengineering"],"abstract":"<jats:p>Prosthetic joint infections (PJIs) remain a major challenge in orthopedic surgery due to the increasing prevalence of antimicrobial-resistant pathogens and their ability to form biofilms on implant surfaces. Local delivery of non-traditional antimicrobials through implant-associated biomaterials represents a promising strategy for preventing bacterial colonization while minimizing systemic antibiotic exposure. This study evaluated the antimicrobial activity and cytocompatibility of two bacteriophages (Phage K and Phage F1) and two antimicrobial peptide dendrimers (AMPDs; TNS18 and G3KL) against clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis recovered from PJIs. Antimicrobial efficacy was assessed using solid and liquid culture assays, while cytocompatibility was evaluated using human osteoblast progenitor cells. Biofilm formation was also investigated under various in vitro conditions. Phages K and F1 demonstrated strong antibacterial activity against S. aureus isolates, whereas TNS18 showed pronounced inhibitory effects against S. epidermidis. All agents exhibited appropriate osteoblast compatibility, except Phage F1, at the highest multiplicity of infection tested. Biofilm formation was observed under several culture conditions, although substantial variability in biofilm stability limited the quantitative assessment of antimicrobial activity. These findings demonstrate complementary antimicrobial activity profiles between bacteriophages and AMPDs and support their further investigation as candidates for implant-associated antimicrobial delivery systems and orthopedic implant coatings.<\/jats:p>","DOI":"10.3390\/bioengineering13080870","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T08:52:01Z","timestamp":1785228721000},"page":"870","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Complementary Activities of Bacteriophages and Antimicrobial Peptide Dendrimers Against Prosthetic Joint Infection Pathogens"],"prefix":"10.3390","volume":"13","author":[{"given":"Shawna","family":"McCallin","sequence":"first","affiliation":[{"name":"Regenerative Therapy Unit, Lausanne University Hospital (CHUV), 1011 Lausanne, Switzerland"},{"name":"Department of Neuro-Urology, Balgrist University Hospital, University of Zurich, 8008 Zurich, Switzerland"},{"name":"Spinal Cord Injury Center, Balgrist University Hospital, University of Zurich, 8008 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Lanz","sequence":"additional","affiliation":[{"name":"Regenerative Therapy Unit, Lausanne University Hospital (CHUV), 1011 Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Jaccoud","sequence":"additional","affiliation":[{"name":"Regenerative Therapy Unit, Lausanne University Hospital (CHUV), 1011 Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5738-8702","authenticated-orcid":false,"given":"Alexis E.","family":"Laurent","sequence":"additional","affiliation":[{"name":"Manufacturing Department, Tec-Pharma SA, 1038 Bercher, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7346-9921","authenticated-orcid":false,"given":"Lee Ann","family":"Applegate","sequence":"additional","affiliation":[{"name":"Regenerative Therapy Unit, Lausanne University Hospital (CHUV), 1011 Lausanne, Switzerland"},{"name":"Manufacturing Department, Tec-Pharma SA, 1038 Bercher, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6054-0573","authenticated-orcid":false,"given":"Philippe","family":"Abdel-Sayed","sequence":"additional","affiliation":[{"name":"Regenerative Therapy Unit, Lausanne University Hospital (CHUV), 1011 Lausanne, Switzerland"},{"name":"Discovering Learning Labs, Ecole Polytechnique F\u00e9d\u00e9rale de Lausanne (EPFL), 1015 Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Kunutsor, S.K., Whitehouse, M.R., Lenguerrand, E., Blom, A.W., Beswick, A.D., and INFORM Team (2016). Re-Infection Outcomes Following One- and Two-Stage Surgical Revision of Infected Knee Prosthesis: A Systematic Review and Meta-Analysis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0151537"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/CMR.00111-13","article-title":"Prosthetic Joint Infection","volume":"27","author":"Tande","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.284.5418.1318","article-title":"Bacterial Biofilms: A Common Cause of Persistent Infections","volume":"284","author":"Costerton","year":"1999","journal-title":"Science"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00281-011-0275-7","article-title":"Pathogenesis of Implant-Associated Infection: The Role of the Host","volume":"33","author":"Zimmerli","year":"2011","journal-title":"Semin. Immunopathol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Harrabi, H., Mamona-Kilu, C., Meyer, E., d\u2019Anglejan Chatillon, E., Dournon, N., Bouchand, F., Duran, C., Perronne, V., Jaffal, K., and Dinh, A. (2025). Treatment Duration in Bacterial Prosthetic Joint Infections: A Narrative Review of Current Evidence. Antibiotics, 14.","DOI":"10.20944\/preprints202505.2388.v1"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41579-018-0019-y","article-title":"Implant Infections: Adhesion, Biofilm Formation and Immune Evasion","volume":"16","author":"Arciola","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1128\/CMR.00109-13","article-title":"Coagulase-Negative Staphylococci","volume":"27","author":"Becker","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJMcp0905029","article-title":"Infection Associated with Prosthetic Joints","volume":"361","author":"Patel","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1128\/CMR.15.2.167-193.2002","article-title":"Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms","volume":"15","author":"Donlan","year":"2002","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_10","unstructured":"Global Coordination and Partnership (GCP) (2025). Analysis of Antibacterial Agents in Clinical and Preclinical Development: Overview and Analysis 2025, World Health Organization."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global Burden of Bacterial Antimicrobial Resistance 1990\u20132021: A Systematic Analysis with Forecasts to 2050","volume":"404","author":"Naghavi","year":"2024","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Calais, G.B., Garcia, G.D., De Moura J\u00fanior, C.F., Soares, J.D.M., Lona, L.M.F., Beppu, M.M., Hernandez-Montelongo, J., and Rocha Neto, J.B.M. (2025). Therapeutic Functions of Medical Implants from Various Material Categories with Integrated Biomacromolecular Systems. Front. Bioeng. Biotechnol., 12.","DOI":"10.3389\/fbioe.2024.1509397"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"100439","DOI":"10.1016\/j.cobme.2022.100439","article-title":"Smart Orthopedic Biomaterials and Implants","volume":"25","author":"Intravaia","year":"2023","journal-title":"Curr. Opin. Biomed. Eng."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1302\/2058-5241.6.210073","article-title":"A Systematic Review of Phage Therapy Applied to Bone and Joint Infections: An Analysis of Success Rates, Treatment Modalities and Safety","volume":"6","author":"McCallin","year":"2021","journal-title":"EFORT Open Rev."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Wahl, P., Schl\u00e4ppi, M., Loganathan, A., U\u00e7kay, I., Hodel, S., Fritz, B., Scheidegger, J., Djebara, S., Leitner, L., and McCallin, S. (2025). Bacteriophage Therapy Created the Necessary Conditions for Successful Antibiotic Suppression in a Periprosthetic Hip Joint Infection: A Case Report. Front. Med., 12.","DOI":"10.3389\/fmed.2025.1564369"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2217\/fmb.13.47","article-title":"Phage Cocktails and the Future of Phage Therapy","volume":"8","author":"Chan","year":"2013","journal-title":"Future Microbiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4161\/bact.1.2.15845","article-title":"Phage Treatment of Human Infections","volume":"1","author":"Abedon","year":"2011","journal-title":"Bacteriophage"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.chom.2019.01.014","article-title":"Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria","volume":"25","author":"Kortright","year":"2019","journal-title":"Cell Host Microbe"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.mib.2017.09.004","article-title":"Phage Therapy as an Alternative or Complementary Strategy to Prevent and Control Biofilm-Related Infections","volume":"39","author":"Pires","year":"2017","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1128\/AEM.71.4.1836-1842.2005","article-title":"Potential of the Polyvalent Anti-Staphylococcus Bacteriophage K for Control of Antibiotic-Resistant Staphylococci from Hospitals","volume":"71","author":"Ross","year":"2005","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1128\/AEM.01789-14","article-title":"Combined Use of Bacteriophage K and a Novel Bacteriophage to Reduce Staphylococcus aureus Biofilm Formation","volume":"80","author":"Alves","year":"2014","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1111\/1462-2920.14310","article-title":"Metagenome Analysis of Russian and Georgian Pyophage Cocktails and a Placebo-Controlled Safety Trial of Single Phage versus Phage Cocktail in Healthy Staphylococcus aureus Carriers","volume":"20","author":"McCallin","year":"2018","journal-title":"Environ. Microbiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.3390\/v7122958","article-title":"What Can We Learn from a Metagenomic Analysis of a Georgian Bacteriophage Cocktail?","volume":"7","author":"Zschach","year":"2015","journal-title":"Viruses"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Ajuebor, J., Buttimer, C., Arroyo-Moreno, S., Chanishvili, N., Gabriel, E.M., O\u2019Mahony, J., McAuliffe, O., Neve, H., Franz, C., and Coffey, A. (2018). Comparison of Staphylococcus Phage K with Close Phage Relatives Commonly Employed in Phage Therapeutics. Antibiotics, 7.","DOI":"10.3390\/antibiotics7020037"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Gallego, S., Franci, G., Falanga, A., G\u00f3mez, R., Folliero, V., Galdiero, S., De La Mata, F., and Galdiero, M. (2017). Function Oriented Molecular Design: Dendrimers as Novel Antimicrobials. Molecules, 22.","DOI":"10.3390\/molecules22101581"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"12827","DOI":"10.1002\/anie.201409270","article-title":"Combining Topology and Sequence Design for the Discovery of Potent Antimicrobial Peptide Dendrimers against Multidrug-Resistant Pseudomonas aeruginosa","volume":"53","author":"Stach","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"22020","DOI":"10.1038\/srep22020","article-title":"Anti-Microbial Dendrimers against Multidrug-Resistant P. Aeruginosa Enhance the Angiogenic Effect of Biological Burn-Wound Bandages","volume":"6","author":"Kaeppeli","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1021\/jacs.7b11037","article-title":"Lipidated Peptide Dendrimers Killing Multidrug-Resistant Bacteria","volume":"140","author":"Siriwardena","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s12985-024-02580-y","article-title":"Evaluation of Effectiveness of Bacteriophage Purification Methods","volume":"21","author":"Tucci","year":"2024","journal-title":"Virol. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1472-765X.2007.02190.x","article-title":"Susceptibility of Staphylococcus Epidermidis Planktonic Cells and Biofilms to the Lytic Action of Staphylococcus Bacteriophage K","volume":"45","author":"Cerca","year":"2007","journal-title":"Lett. Appl. Microbiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1128\/jb.98.2.519-527.1969","article-title":"Use of Bacteriophage-Resistant Mutants to Study the Nature of the Bacteriophage Receptor Site of Staphylococcus aureus","volume":"98","author":"Chatterjee","year":"1969","journal-title":"J. Bacteriol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.carres.2004.03.017","article-title":"Structural Elucidation of the Extracellular and Cell-Wall Teichoic Acids of Staphylococcus Epidermidis RP62A, a Reference Biofilm-Positive Strain","volume":"339","author":"Sadovskaya","year":"2004","journal-title":"Carbohydr. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1038\/s41598-018-20222-6","article-title":"Analysis of Staphylococcus aureus Wall Teichoic Acid Glycoepitopes by Fourier Transform Infrared Spectroscopy Provides Novel Insights into the Staphylococcal Glycocode","volume":"8","author":"Grunert","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Ferry, T., Kolenda, C., Briot, T., Souche, A., Lustig, S., Josse, J., Batailler, C., Pirot, F., Medina, M., and Leboucher, G. (2021). Past and Future of Phage Therapy and Phage-Derived Proteins in Patients with Bone and Joint Infection. Viruses, 13.","DOI":"10.3390\/v13122414"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e02247-21","DOI":"10.1128\/aac.02247-21","article-title":"Antibiotic Exposure Leads to Reduced Phage Susceptibility in Vancomycin Intermediate Staphylococcus aureus (VISA)","volume":"66","author":"McCallin","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1099\/jmm.0.025619-0","article-title":"Resistance of Staphylococcus aureus to the Cationic Antimicrobial Agent Poly(2-(Dimethylamino Ethyl)Methacrylate) (pDMAEMA) Is Influenced by Cell-Surface Charge and Hydrophobicity","volume":"60","author":"Rawlinson","year":"2011","journal-title":"J. Med. Microbiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"6824","DOI":"10.1128\/JB.182.23.6824-6826.2000","article-title":"Alternative Transcription Factor Sigma(B) Is Involved in Regulation of Biofilm Expression in a Staphylococcus aureus Mucosal Isolate","volume":"182","author":"Rachid","year":"2000","journal-title":"J. Bacteriol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.mimet.2012.04.009","article-title":"An Improved Medium for Growing Staphylococcus aureus Biofilm","volume":"90","author":"Chen","year":"2012","journal-title":"J. Microbiol. Methods"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1093\/infdis\/jiv319","article-title":"An Essential Role for Coagulase in Staphylococcus aureus Biofilm Development Reveals New Therapeutic Possibilities for Device-Related Infections","volume":"212","author":"Zapotoczna","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Zapotoczna, M., O\u2019Neill, E., and O\u2019Gara, J.P. (2016). Untangling the Diverse and Redundant Mechanisms of Staphylococcus aureus Biofilm Formation. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005671"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"E11771","DOI":"10.1073\/pnas.1804850115","article-title":"Staphylococcus aureus Coagulases Are Exploitable yet Stable Public Goods in Clinically Relevant Conditions","volume":"115","author":"Trivedi","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Eijkel, B.I.M., Apachitei, I., Fratila-Apachitei, L.E., and Zadpoor, A.A. (2024). In Vitro Co-Culture Models for the Assessment of Orthopedic Antibacterial Biomaterials. Front. Bioeng. Biotechnol., 12.","DOI":"10.3389\/fbioe.2024.1332771"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"987","DOI":"10.2217\/fmb.14.64","article-title":"Biofilms in Periprosthetic Orthopedic Infections","volume":"9","author":"McConoughey","year":"2014","journal-title":"Future Microbiol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Br\u00fcmmer, N., Doll-Nikutta, K., Schadzek, P., Mikolai, C., Kampmann, A., Wirth, D., Hoffmann, A., Pott, P.-C., Karras, O., and Auer, S. (2025). Better Models, Better Treatment? A Systematic Review of Current Three Dimensional (3D) in Vitro Models for Implant-Associated Infections. Front. Bioeng. Biotechnol., 13.","DOI":"10.3389\/fbioe.2025.1569211"}],"container-title":["Bioengineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2306-5354\/13\/8\/870\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T09:05:45Z","timestamp":1785229545000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2306-5354\/13\/8\/870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":44,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["bioengineering13080870"],"URL":"https:\/\/doi.org\/10.3390\/bioengineering13080870","relation":{},"ISSN":["2306-5354"],"issn-type":[{"value":"2306-5354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]}}}